Cargando…

TNFAIP8 variants as potential epidemiological and predictive biomarkers in ovarian cancer

BACKGROUND: This research aimed to investigate the association between tumor necrosis factor-a-induced protein 8 (TNFAIP8) polymorphisms and ovarian cancer (OC) susceptibility. METHODS: A case–control study of 210 patients with OC and 231 healthy controls was conducted to assess the association betw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Hongyu, Zhang, Zhiran, Jiang, Liangliang, Zhang, Lei, Qin, Ling, Liu, Tianbo, Yang, Shanshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433149/ https://www.ncbi.nlm.nih.gov/pubmed/32821249 http://dx.doi.org/10.1186/s12935-020-01490-7

Ejemplares similares

Association of TNFAIP8 gene polymorphisms with endometrial cancer in northern Chinese women
por: Liu, Tianbo, et al.
Publicado: (2019)

TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma
por: Chen, Cunte, et al.
Publicado: (2021)

LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway
por: Li, Yang, et al.
Publicado: (2020)

TNFAIP8 as a predictor of metastasis and a novel prognostic biomarker in patients with epithelial ovarian cancer
por: Liu, T, et al.
Publicado: (2013)

Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments
por: Gao, Lingling, et al.
Publicado: (2020)

KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells
por: Chen, Hong, et al.
Publicado: (2016)

Susceptibility of TNFAIP8, TNFAIP8L1, and TNFAIP2 Gene Polymorphisms on Cancer Risk: A Comprehensive Review and Meta-Analysis of Case–Control Studies
por: Bhowmik, Khokon Kanti, et al.
Publicado: (2022)

TNFAIP8 promotes cell growth by regulating the Hippo pathway in epithelial ovarian cancer
por: Xie, Yao, et al.
Publicado: (2018)

TNFAIP8 family gene expressions in the mouse tail intervertebral disc injury model
por: Tian, Zuozhen, et al.
Publicado: (2020)

TNFAIP8: Inflammation, Immunity and Human Diseases
por: Niture, Suryakant, et al.
Publicado: (2019)

Ovarian cyst removal influences ovarian reserve dependent on histology, size and type of operation
por: Henes, Melanie, et al.
Publicado: (2018)

Bioinformatics combined with quantitative proteomics analyses and identification of potential biomarkers in cholangiocarcinoma
por: Da, Zijian, et al.
Publicado: (2020)

miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer
por: Yu, Xiaotang, et al.
Publicado: (2020)

NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma
por: Zhao, Cui, et al.
Publicado: (2021)

SNAP25 is a potential prognostic biomarker for prostate cancer
por: Di, Longjiang, et al.
Publicado: (2022)

Identification of TNFAIP8 as an Immune-Related Biomarker Associated With Tumorigenesis and Prognosis in Cutaneous Melanoma Patients
por: Sun, Yuliang, et al.
Publicado: (2021)

VWCE as a potential biomarker associated with immune infiltrates in breast cancer
por: Huo, Qin, et al.
Publicado: (2021)

Comprehensive analysis of LDHAP5 pseudogene expression and potential pathogenesis in ovarian serous cystadenocarcinoma
por: Lin, Shitong, et al.
Publicado: (2020)

Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico
por: Chen, Jingxuan, et al.
Publicado: (2020)

Potential new biomarkers for endometrial cancer
por: Townsend, Michelle H., et al.
Publicado: (2019)

NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
por: Tao, Wenjie, et al.
Publicado: (2021)

YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022)

Pathogenic variants identified by whole-exome sequencing in 43 patients with epilepsy
por: Zhang, Linlin, et al.
Publicado: (2020)

Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma
por: Cheng, Xingbo, et al.
Publicado: (2022)

FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer
por: Xie, Qin, et al.
Publicado: (2020)

FOXD3 may be a new cellular target biomarker as a hypermethylation gene in human ovarian cancer
por: Luo, Gui-fang, et al.
Publicado: (2019)

Serum-derived exosomes promote CD8+ T cells to overexpress PD-1, affecting the prognosis of hypopharyngeal carcinoma
por: Gao, Qian, et al.
Publicado: (2021)

Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases
por: Saxena, Shrishti, et al.
Publicado: (2020)

Integrated analysis reveals potential long non-coding RNA biomarkers and their potential biological functions for disease free survival in gastric cancer patients
por: Cheng, Canchang, et al.
Publicado: (2019)

PAX8 expression in high-grade serous ovarian cancer positively regulates attachment to ECM via Integrin β3
por: Soriano, Amata Amy, et al.
Publicado: (2019)

Oncogenic Role of Tumor Necrosis Factor α-Induced Protein 8 (TNFAIP8)
por: Niture, Suryakant, et al.
Publicado: (2018)

TNFAIP8 promotes prostate cancer cell survival by inducing autophagy
por: Niture, Suryakant, et al.
Publicado: (2018)

MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma
por: Zhang, Jun-feng, et al.
Publicado: (2018)

HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer
por: Xu, Guocai, et al.
Publicado: (2021)

Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer
por: Yu, Jing, et al.
Publicado: (2021)

Identification of potential biomarkers and candidate small molecule drugs in glioblastoma
por: Lu, Wei-cheng, et al.
Publicado: (2020)

MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer
por: Wang, Jiaqi, et al.
Publicado: (2016)

TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway
por: Xing, Ying, et al.
Publicado: (2018)

CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma
por: Su, Jinfang, et al.
Publicado: (2022)

Expression of PAWR predicts prognosis of ovarian cancer
por: Tan, Jiahong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rgv48f5bf63ep2h65nd1rjn0k4